APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Poloxamer Market Outlook and Growth Opportunities 2026

27 December 2025194 pages

Choose your research edition.

Industry ResearchPoloxamer Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Poloxamer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Poloxamer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poloxamer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Poloxamer market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Poloxamer market include BASF, ADEKA, Croda, Nanjing Well, Hubei Hengshuo, Solvay and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Poloxamer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Poloxamer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Poloxamer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Poloxamer market size, projected growth trends, production technologies, key applications, and end-use industries.

Poloxamer Segment by Company

BASF

ADEKA

Croda

Nanjing Well

Hubei Hengshuo

Solvay

Merck KGaA

Poloxamer Segment by Type

Poloxamer 124

Poloxamer 184

Poloxamer 188

Poloxamer 338

Poloxamer 407

Others

Poloxamer Segment by Application

Cosmetics Industrial

Biologics

Pharmaceutical Industrial

Others

Poloxamer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Poloxamer status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Poloxamer market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Poloxamer significant trends, drivers, influence factors in global and regions.

6. To analyze Poloxamer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Poloxamer market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Poloxamer industry.

Chapter 3: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Poloxamer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Poloxamer in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Poloxamer Industry Trends Table 2. Poloxamer Industry Drivers Table 3. Poloxamer Industry Opportunities and Challenges Table 4. Poloxamer Industry Restraints Table 5. Global Poloxamer Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Poloxamer Revenue Share by Company (2021-2026) Table 7. Global Poloxamer Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Poloxamer Sales Volume Share by Company (2021-2026) Table 9. Global Poloxamer Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Poloxamer Company Ranking, (2024-2026) & (USD Million) Table 11. Global Poloxamer Key Company Manufacturing Base & Headquarters Table 12. Global Poloxamer Company, Product Type & Application Table 13. Global Poloxamer Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Poloxamer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Poloxamer 124 Table 18. Significant Companies of Poloxamer 184 Table 19. Significant Companies of Poloxamer 188 Table 20. Significant Companies of Poloxamer 338 Table 21. Significant Companies of Poloxamer 407 Table 22. Significant Companies of Others Table 23. Global Poloxamer Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Poloxamer Sales Volume by Type (2021-2026) & (Tons) Table 25. Global Poloxamer Sales Volume by Type (2027-2032) & (Tons) Table 26. Global Poloxamer Sales Volume Share by Type (2021-2026) Table 27. Global Poloxamer Sales Volume Share by Type (2027-2032) Table 28. Global Poloxamer Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Poloxamer Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Poloxamer Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Poloxamer Sales Value Share by Type (2021-2026) Table 32. Global Poloxamer Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Cosmetics Industrial Table 34. Significant Companies of Biologics Table 35. Significant Companies of Pharmaceutical Industrial Table 36. Significant Companies of Others Table 37. Global Poloxamer Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Poloxamer Sales Volume by Application (2021-2026) & (Tons) Table 39. Global Poloxamer Sales Volume by Application (2027-2032) & (Tons) Table 40. Global Poloxamer Sales Volume Share by Application (2021-2026) Table 41. Global Poloxamer Sales Volume Share by Application (2027-2032) Table 42. Global Poloxamer Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Poloxamer Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Poloxamer Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Poloxamer Sales Value Share by Application (2021-2026) Table 46. Global Poloxamer Sales Value Share by Application (2027-2032) Table 47. Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 48. Global Poloxamer Sales by Region (2021-2026) & (Tons) Table 49. Global Poloxamer Sales Market Share by Region (2021-2026) Table 50. Global Poloxamer Sales by Region (2027-2032) & (Tons) Table 51. Global Poloxamer Sales Market Share by Region (2027-2032) Table 52. Global Poloxamer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Poloxamer Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Poloxamer Sales Value Share by Region (2021-2026) Table 55. Global Poloxamer Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Poloxamer Sales Value Share by Region (2027-2032) Table 57. Global Poloxamer Market Average Price (US$/Ton) by Region (2021-2026) Table 58. Global Poloxamer Market Average Price (US$/Ton) by Region (2027-2032) Table 59. Global Poloxamer Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 60. Global Poloxamer Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Poloxamer Sales by Country (2021-2026) & (Tons) Table 62. Global Poloxamer Sales Market Share by Country (2021-2026) Table 63. Global Poloxamer Sales by Country (2027-2032) & (Tons) Table 64. Global Poloxamer Sales Market Share by Country (2027-2032) Table 65. Global Poloxamer Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Poloxamer Sales Value Market Share by Country (2021-2026) Table 67. Global Poloxamer Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Poloxamer Sales Value Market Share by Country (2027-2032) Table 69. BASF Company Information Table 70. BASF Business Overview Table 71. BASF Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. BASF Poloxamer Product Portfolio Table 73. BASF Recent Development Table 74. ADEKA Company Information Table 75. ADEKA Business Overview Table 76. ADEKA Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. ADEKA Poloxamer Product Portfolio Table 78. ADEKA Recent Development Table 79. Croda Company Information Table 80. Croda Business Overview Table 81. Croda Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Croda Poloxamer Product Portfolio Table 83. Croda Recent Development Table 84. Nanjing Well Company Information Table 85. Nanjing Well Business Overview Table 86. Nanjing Well Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Nanjing Well Poloxamer Product Portfolio Table 88. Nanjing Well Recent Development Table 89. Hubei Hengshuo Company Information Table 90. Hubei Hengshuo Business Overview Table 91. Hubei Hengshuo Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Hubei Hengshuo Poloxamer Product Portfolio Table 93. Hubei Hengshuo Recent Development Table 94. Solvay Company Information Table 95. Solvay Business Overview Table 96. Solvay Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Solvay Poloxamer Product Portfolio Table 98. Solvay Recent Development Table 99. Merck KGaA Company Information Table 100. Merck KGaA Business Overview Table 101. Merck KGaA Poloxamer Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Merck KGaA Poloxamer Product Portfolio Table 103. Merck KGaA Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Poloxamer Distributors List Table 107. Poloxamer Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Poloxamer Product Image Figure 2. Global Poloxamer Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 4. Global Poloxamer Sales (2021-2032) & (Tons) Figure 5. Global Poloxamer Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Poloxamer Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Poloxamer 124 Image Figure 10. Poloxamer 184 Image Figure 11. Poloxamer 188 Image Figure 12. Poloxamer 338 Image Figure 13. Poloxamer 407 Image Figure 14. Others Image Figure 15. Global Poloxamer Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Poloxamer Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Poloxamer Sales Volume Share by Type (2021-2032) Figure 18. Global Poloxamer Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Poloxamer Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Poloxamer Sales Value Share by Type (2021-2032) Figure 21. Cosmetics Industrial Image Figure 22. Biologics Image Figure 23. Pharmaceutical Industrial Image Figure 24. Others Image Figure 25. Global Poloxamer Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Poloxamer Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Poloxamer Sales Volume Share by Application (2021-2032) Figure 28. Global Poloxamer Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Poloxamer Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Poloxamer Sales Value Share by Application (2021-2032) Figure 31. Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 32. Global Poloxamer Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Poloxamer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Poloxamer Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 36. North America Poloxamer Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Poloxamer Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Poloxamer Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 42. South America Poloxamer Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Poloxamer Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Poloxamer Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Poloxamer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Poloxamer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Poloxamer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Poloxamer Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Poloxamer Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Poloxamer 124
  • Poloxamer 184
  • Poloxamer 188
  • Poloxamer 338
  • Poloxamer 407
  • Others
Applications
  • Cosmetics Industrial
  • Biologics
  • Pharmaceutical Industrial
  • Others
Companies covered
  • BASF
  • ADEKA
  • Croda
  • Nanjing Well
  • Hubei Hengshuo
  • Solvay
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poloxamer Sales Value (2021-2032)
  4. 1.2.2 Global Poloxamer Sales Volume (2021-2032)
  5. 1.2.3 Global Poloxamer Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Poloxamer Market Dynamics
  1. 2.1 Poloxamer Industry Trends
  2. 2.2 Poloxamer Industry Drivers
  3. 2.3 Poloxamer Industry Opportunities and Challenges
  4. 2.4 Poloxamer Industry Restraints
3 Poloxamer Market by Company
  1. 3.1 Global Poloxamer Company Revenue Ranking in 2025
  2. 3.2 Global Poloxamer Revenue by Company (2021-2026)
  3. 3.3 Global Poloxamer Sales Volume by Company (2021-2026)
  4. 3.4 Global Poloxamer Average Price by Company (2021-2026)
  5. 3.5 Global Poloxamer Company Ranking (2024-2026)
  6. 3.6 Global Poloxamer Company Manufacturing Base and Headquarters
  7. 3.7 Global Poloxamer Company Product Type and Application
  8. 3.8 Global Poloxamer Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Poloxamer Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Poloxamer Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Poloxamer Market by Type
  1. 4.1 Poloxamer Type Introduction
  2. 4.1.1 Poloxamer 124
  3. 4.1.2 Poloxamer 184
  4. 4.1.3 Poloxamer 188
  5. 4.1.4 Poloxamer 338
  6. 4.1.5 Poloxamer 407
  7. 4.1.6 Others
  8. 4.2 Global Poloxamer Sales Volume by Type
  9. 4.2.1 Global Poloxamer Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Poloxamer Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Poloxamer Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Poloxamer Sales Value by Type
  13. 4.3.1 Global Poloxamer Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Poloxamer Sales Value by Type (2021-2032)
  15. 4.3.3 Global Poloxamer Sales Value Share by Type (2021-2032)
5 Poloxamer Market by Application
  1. 5.1 Poloxamer Application Introduction
  2. 5.1.1 Cosmetics Industrial
  3. 5.1.2 Biologics
  4. 5.1.3 Pharmaceutical Industrial
  5. 5.1.4 Others
  6. 5.2 Global Poloxamer Sales Volume by Application
  7. 5.2.1 Global Poloxamer Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Poloxamer Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Poloxamer Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Poloxamer Sales Value by Application
  11. 5.3.1 Global Poloxamer Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Poloxamer Sales Value by Application (2021-2032)
  13. 5.3.3 Global Poloxamer Sales Value Share by Application (2021-2032)
6 Poloxamer Regional Sales and Value Analysis
  1. 6.1 Global Poloxamer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Poloxamer Sales by Region (2021-2032)
  3. 6.2.1 Global Poloxamer Sales by Region: 2021-2026
  4. 6.2.2 Global Poloxamer Sales by Region (2027-2032)
  5. 6.3 Global Poloxamer Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Poloxamer Sales Value by Region (2021-2032)
  7. 6.4.1 Global Poloxamer Sales Value by Region: 2021-2026
  8. 6.4.2 Global Poloxamer Sales Value by Region (2027-2032)
  9. 6.5 Global Poloxamer Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Poloxamer Sales Value (2021-2032)
  12. 6.6.2 North America Poloxamer Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Poloxamer Sales Value (2021-2032)
  15. 6.7.2 Europe Poloxamer Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Poloxamer Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Poloxamer Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Poloxamer Sales Value (2021-2032)
  21. 6.9.2 South America Poloxamer Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Poloxamer Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Poloxamer Sales Value Share by Country, 2025 VS 2032
7 Poloxamer Country-level Sales and Value Analysis
  1. 7.1 Global Poloxamer Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Poloxamer Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Poloxamer Sales by Country (2021-2032)
  4. 7.3.1 Global Poloxamer Sales by Country (2021-2026)
  5. 7.3.2 Global Poloxamer Sales by Country (2027-2032)
  6. 7.4 Global Poloxamer Sales Value by Country (2021-2032)
  7. 7.4.1 Global Poloxamer Sales Value by Country (2021-2026)
  8. 7.4.2 Global Poloxamer Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Poloxamer Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Poloxamer Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Poloxamer Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Poloxamer Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Poloxamer Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Poloxamer Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Poloxamer Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Poloxamer Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Poloxamer Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Poloxamer Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Poloxamer Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Poloxamer Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Poloxamer Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Poloxamer Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Poloxamer Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Poloxamer Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Poloxamer Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Poloxamer Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Poloxamer Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Poloxamer Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Poloxamer Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Poloxamer Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Poloxamer Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Poloxamer Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Poloxamer Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Poloxamer Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Poloxamer Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Poloxamer Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Poloxamer Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Poloxamer Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Poloxamer Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Poloxamer Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Poloxamer Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Poloxamer Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Poloxamer Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Poloxamer Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Poloxamer Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Poloxamer Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Poloxamer Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Poloxamer Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Poloxamer Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Poloxamer Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Poloxamer Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Poloxamer Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Poloxamer Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Poloxamer Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Poloxamer Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Poloxamer Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Poloxamer Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Poloxamer Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Poloxamer Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Poloxamer Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Poloxamer Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Poloxamer Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Poloxamer Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Poloxamer Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Poloxamer Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Poloxamer Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Poloxamer Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Poloxamer Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Poloxamer Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Poloxamer Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Poloxamer Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Poloxamer Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Poloxamer Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Poloxamer Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Poloxamer Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Poloxamer Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Poloxamer Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Poloxamer Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Poloxamer Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Poloxamer Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Poloxamer Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Poloxamer Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Poloxamer Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Poloxamer Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Poloxamer Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Poloxamer Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Poloxamer Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Poloxamer Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Poloxamer Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Poloxamer Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Poloxamer Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Poloxamer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Poloxamer Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Poloxamer Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 ADEKA
  8. 8.2.1 ADEKA Company Information
  9. 8.2.2 ADEKA Business Overview
  10. 8.2.3 ADEKA Poloxamer Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ADEKA Poloxamer Product Portfolio
  12. 8.2.5 ADEKA Recent Developments
  13. 8.3 Croda
  14. 8.3.1 Croda Company Information
  15. 8.3.2 Croda Business Overview
  16. 8.3.3 Croda Poloxamer Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Croda Poloxamer Product Portfolio
  18. 8.3.5 Croda Recent Developments
  19. 8.4 Nanjing Well
  20. 8.4.1 Nanjing Well Company Information
  21. 8.4.2 Nanjing Well Business Overview
  22. 8.4.3 Nanjing Well Poloxamer Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Well Poloxamer Product Portfolio
  24. 8.4.5 Nanjing Well Recent Developments
  25. 8.5 Hubei Hengshuo
  26. 8.5.1 Hubei Hengshuo Company Information
  27. 8.5.2 Hubei Hengshuo Business Overview
  28. 8.5.3 Hubei Hengshuo Poloxamer Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Hengshuo Poloxamer Product Portfolio
  30. 8.5.5 Hubei Hengshuo Recent Developments
  31. 8.6 Solvay
  32. 8.6.1 Solvay Company Information
  33. 8.6.2 Solvay Business Overview
  34. 8.6.3 Solvay Poloxamer Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Solvay Poloxamer Product Portfolio
  36. 8.6.5 Solvay Recent Developments
  37. 8.7 Merck KGaA
  38. 8.7.1 Merck KGaA Company Information
  39. 8.7.2 Merck KGaA Business Overview
  40. 8.7.3 Merck KGaA Poloxamer Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck KGaA Poloxamer Product Portfolio
  42. 8.7.5 Merck KGaA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Poloxamer Value Chain Analysis
  2. 9.1.1 Poloxamer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Poloxamer Sales Mode & Process
  6. 9.2 Poloxamer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Poloxamer Distributors
  9. 9.2.3 Poloxamer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst